Coherus Oncology Inc

CHRSNASDAQ · USD
0.51USD0.00 (-3.73%)
322

Coherus Oncology Inc (CHRS) Options Open Interest

CHRS options open interest is 22,093 contracts. The 2-week average daily volume is 436 contracts across the chain.

Read more

Monitoring CHRS open interest helps you see where real money is positioned on Coherus Oncology Inc's options and which strikes are attracting the most commitment from traders. Coherus Oncology Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor CHRS options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising CHRS options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Coherus Oncology Inc to settle.

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin 27. It also develops CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, Anti-ILT4 monoclonal antibody for solid tumors.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where CHRS open interest is concentrated. Our scanner maps Coherus Oncology Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Coherus Oncology Inc's options open interest as the signal it is, not as an afterthought.

2026-11-20
Calls
2.00—0.050.05780%+0.23534,229
1.50—0.050.05679%+0.25323,376
3.00—0.450.451,000%+0.27581,360
1.00—0.450.451,000%+0.5844658
4.00—0.050.05997%+0.2079493
Puts
2.001.152.151.651,000%-0.61671,160
1.500.651.651.151,000%-0.5340401
1.000.151.150.65989%-0.420775
0.50—0.050.05230%-0.365049
3.002.103.102.601,000%-0.72420

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →